Bates SE - Search Results

1

Inhibition of ABCG2-mediated transport by protein kinase inhibitors with a bisindolylmaleimide or indolocarbazole structure.

Robey RW, Shukla S, Steadman K, Obrzut T, Finley EM, Ambudkar SV, Bates SE. Robey RW, et al. Among authors: bates se. Mol Cancer Ther. 2007 Jun;6(6):1877-85. doi: 10.1158/1535-7163.MCT-06-0811. Mol Cancer Ther. 2007. PMID: 17575116

2

Contribution of glutathione and glutathione-dependent enzymes in the reversal of adriamycin resistance in colon carcinoma cell lines.

Lai GM, Moscow JA, Alvarez MG, Fojo AT, Bates SE. Lai GM, et al. Among authors: bates se. Int J Cancer. 1991 Nov 11;49(5):688-95. doi: 10.1002/ijc.2910490511. Int J Cancer. 1991. PMID: 1682279

3

P-glycoprotein expression and schedule dependence of adriamycin cytotoxicity in human colon carcinoma cell lines.

Lai GM, Chen YN, Mickley LA, Fojo AT, Bates SE. Lai GM, et al. Among authors: bates se. Int J Cancer. 1991 Nov 11;49(5):696-703. doi: 10.1002/ijc.2910490512. Int J Cancer. 1991. PMID: 1682280

4

Differential modulation of P-glycoprotein transport by protein kinase inhibition.

Bates SE, Lee JS, Dickstein B, Spolyar M, Fojo AT. Bates SE, et al. Biochemistry. 1993 Sep 7;32(35):9156-64. doi: 10.1021/bi00086a022. Biochemistry. 1993. PMID: 7690250

5

Chemoresistance in the clinic: overview 1994.

Bates SE, Regis JI, Robey RW, Zhan Z, Scala S, Meadows BJ. Bates SE, et al. Bull Cancer. 1994 Dec;81 Suppl 2:55s-61s. Bull Cancer. 1994. PMID: 7727860 Review.

6

Rhodamine efflux patterns predict P-glycoprotein substrates in the National Cancer Institute drug screen.

Lee JS, Paull K, Alvarez M, Hose C, Monks A, Grever M, Fojo AT, Bates SE. Lee JS, et al. Among authors: bates se. Mol Pharmacol. 1994 Oct;46(4):627-38. Mol Pharmacol. 1994. PMID: 7969041

7

Normal p53 status and function despite the development of drug resistance in human breast cancer cells.

Wosikowski K, Regis JT, Robey RW, Alvarez M, Buters JT, Gudas JM, Bates SE. Wosikowski K, et al. Among authors: bates se. Cell Growth Differ. 1995 Nov;6(11):1395-403. Cell Growth Differ. 1995. PMID: 8562478

8

Brain-derived neurotrophic factor protects neuroblastoma cells from vinblastine toxicity.

Scala S, Wosikowski K, Giannakakou P, Valle P, Biedler JL, Spengler BA, Lucarelli E, Bates SE, Thiele CJ. Scala S, et al. Among authors: bates se. Cancer Res. 1996 Aug 15;56(16):3737-42. Cancer Res. 1996. PMID: 8706017

9

Clinical reversal of multidrug resistance.

Bates SE, Wilson WH, Fojo AT, Alvarez M, Zhan Z, Regis J, Robey R, Hose C, Monks A, Kang YK, Chabner B. Bates SE, et al. Stem Cells. 1996 Jan;14(1):56-63. doi: 10.1002/stem.140056. Stem Cells. 1996. PMID: 8820952 Review.

10

Reduced drug accumulation and multidrug resistance in human breast cancer cells without associated P-glycoprotein or MRP overexpression.

Lee JS, Scala S, Matsumoto Y, Dickstein B, Robey R, Zhan Z, Altenberg G, Bates SE. Lee JS, et al. Among authors: bates se. J Cell Biochem. 1997 Jun 15;65(4):513-26. J Cell Biochem. 1997. PMID: 9178101

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

416 results

Search Page

Filters